Unique ID issued by UMIN | UMIN000002578 |
---|---|
Receipt number | R000003143 |
Scientific Title | Microdosing cinical studies -Assesment of oral bioavailability of drugs by cassete IV and PO dosing- |
Date of disclosure of the study information | 2009/10/03 |
Last modified on | 2009/10/03 05:39:23 |
Microdosing cinical studies -Assesment of oral bioavailability of drugs by cassete IV and PO dosing-
Cassete microdosing study for assement of bioavailability using 3 calcium antagonisits
Microdosing cinical studies -Assesment of oral bioavailability of drugs by cassete IV and PO dosing-
Cassete microdosing study for assement of bioavailability using 3 calcium antagonisits
Japan |
hypertension, arrhythmia
Medicine in general | Gastroenterology | Cardiology |
Others
NO
Purposes of this project are 1) to investigate the Miclodosing (MD) clinical study to accelerate the development of oral drug products 2) to develop a rationale method to assess the oral absorbability of drugs by MD study and 3) to simulate the human BA of drugs based on the in vitro and in vivo (MD) studies.
Bio-availability
Exploratory
Explanatory
Not applicable
Each Cmax,Tmax,AUC 0-T,ACUinf,
and of T1/2 of nifedipine, nicardipine and diltiazem
Interventional
Parallel
Randomized
Open -no one is blinded
Uncontrolled
5
Diagnosis
Medicine |
Single IV cassete microdosing of nifedipine, nicardipine and diltiazem
Single oral cassete microdosing of nifedipine, nicardipine and diltiazem
Single oral clinical dosing of nifedipine
Single oral clinical dosing of nicardipine
Single oral clinical dosing of diltiazem
20 | years-old | <= |
40 | years-old | >= |
Male
1) Healthy male volunteers who are 20~40 years old
2) BMI 18.0~30.0
1)person who has present and/or past history of disease of heart and circulatory system, liver,kidney and uretary system, and digestive system.
2)person who has drug adiction and/or allergy
3)person who takes drugs which has an effect on the result of this study
4)person who is thoght by medical doctor as unsuitable in physical examinations and blood and biochemistry examinations.
5)person who takes drugs and/or health food product like St.John's wort within 7 days before taking study drugs
6)person who juice wfruit within 7 days before taking study drugs including grapefruitjuice
7)person who usually take health food product like St.John's wort
8)person who joined other clinical study within 3 months before this study and is thougt as unsuitable by medical doctor
9)person who donated blood of 200mL within one month and within 3 months before this study
10)person who is positive HBV,HCV,HIV and syphilis
11)person who has allergy of drug and/or food
12)person who addict drugs and alcohol
12)person who is diagonosed by medical doctors as unsuitable for joinining this study
8
1st name | |
Middle name | |
Last name | TAKUYA MORIMOTO |
Oita university hospital
Clinical pharmacology center,Japan
Hasama Idaigaoka 1-1, Yufu city, Oita prefecture
097-586-5952
1st name | |
Middle name | |
Last name | TAKUYA MORIMOTO |
Oita university hospital
Clinical pharmacology center
Hasama Idaigaoka 1-1, Yufu city, Oita prefecture,Japan
Oita university hospital,Clinical pharmacology center
Association for promoting drug development
Other
NO
大分大学医学部附属病院(大分県)
2009 | Year | 10 | Month | 03 | Day |
Unpublished
Open public recruiting
2009 | Year | 07 | Month | 14 | Day |
2009 | Year | 10 | Month | 01 | Day |
2009 | Year | 12 | Month | 01 | Day |
2009 | Year | 10 | Month | 03 | Day |
2009 | Year | 10 | Month | 03 | Day |
Value
https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000003143